Clinical Research Directory

Inclusion Criteria: * Woman with epilepsy between the ages of 18-45 planning pregnancy or in the early first trimester of pregnancy. * Women with epilepsy ability to maintain a daily medical diary * Women with epilepsy ability to answer side effect questionnaires * Women with epilepsy currently being treated with lamotrigine (LTG) or levetiracetam (LEV) or oxcarbazepine (OXC) Exclusion Criteria: * Women with epilepsy having history of functional seizures. * Women with epilepsy history of other major medical illnesses including renal or hepatic disease, progressive cerebral disease, * Women with epilepsy who have inability to maintain a seizure and medication daily diary * Women with epilepsy with present or recent history of drug or alcohol abuse, or the use of any concomitant medications that interact with the ASM they are taking (lamotrigine, levetiracetam, oxcarbazepine).